The co-founder and chief science officer at Longeveron provided commentary on the therapeutic potential of Lomecel-B, a living cell product in development for patients with Alzheimer disease. [WATCH TIME: 3 minutes]
Joshua Hare, MD
Advertisement
Articles by Joshua Hare, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
2
FDA Accepts New Drug Application for Tau PET Imaging Agent MK-6240 in Alzheimer Disease
3
Exenatide Alters Motor Network Activity in Parkinson Disease, Though Clinical Impact Remains Limited
4
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
5
